Alto Neuroscience, Inc. (ANRO) return on equity (ROE)

Return on equity · fiscal 2025
-41.8%

Only 2 fiscal years of return on equity are on record here for Alto Neuroscience, Inc. (ANRO); a history needs at least 3. Figures as of 17 Nov 2026, 20:55 UTC, from Yahoo Finance.

Key facts

Return on equity, fiscal 2025
-41.8%
Change on fiscal 2024
−1.3 pts
Fiscal years on record
22024–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of return on equity needs at least 3 fiscal years; 2 are on record here for Alto Neuroscience, Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Alto Neuroscience, Inc. return on equity (ROE), year by year

Alto Neuroscience, Inc. (ANRO) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2025-41.8% 1.3 pts down
2024-40.6%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on ANRO

Alto Neuroscience, Inc., figure by figure

Alto Neuroscience, Inc. (ANRO) overview: price, valuation and scorecard

Alto Neuroscience, Inc. return on equity (ROE): questions and answers

How is Alto Neuroscience, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alto Neuroscience, Inc. (ANRO) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/ANRO/roe

Underlying data: Yahoo Finance.